National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Shingles
 Cause
 Symptoms
 Diagnosis
 Treatment
 Prevention
 Complications
 Research


Shingles

Prevention

The Centers for Disease Control and Prevention recommends that adults 60 years of age and older get a single dose of the shingles vaccine (called Zostavax) even if they have had a prior episode of shingles.

Health experts estimate the vaccine could prevent 250,000 cases of shingles that occur in the United States each year and significantly reduce the severity of the disease in another 250,000 cases annually.


Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to shingles on ClinicalTrials.gov.

See Also

Viral Infections

Related Links

View a list of links for more information about shingles.

E-mail Icon E-mail this page
Print Icon Print this page

Volunteer for Clinical Studies

Volunteer for NIAID-funded clinical studies related to shingles on ClinicalTrials.gov.

See Also

Viral Infections

Related Links

View a list of links for more information about shingles.